Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Malondialdehyde Assay in the Evaluation of Aspirin Antiplatelet Effects
Amin Polzin1, Lisa Dannenberg2, Theresa Schneider2
1Division of Cardiology, Pulmonology, and Vascular Medicine, Heinrich Heine University Medical Center Düsseldorf, Düsseldorf, Germanyamin.polzin@med.uni-duesseldorf.de.
Insights
A new malondialdehyde (MDA) assay reliably detects high on-treatment platelet reactivity (HTPR) to aspirin, a common issue in cardiovascular prevention. This potential bedside test offers a simpler alternative to complex existing methods for assessing aspirin
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
- Pharmacology
Background:
- Aspirin is crucial for secondary prevention in patients with myocardial infarction and coronary artery disease.
- High on-treatment platelet reactivity (HTPR) to aspirin is frequent, leading to increased cardiovascular events.
- Current assays for aspirin's antiplatelet effects are complex and require specialized laboratory expertise.
Purpose of the Study:
- To develop and validate a novel, potentially bedside assay for determining aspirin's pharmacodynamic response.
- To compare a new malondialdehyde (MDA) assay with conventional methods for assessing aspirin's antiplatelet effects.
Main Methods:
- A fluorometric malondialdehyde (MDA) assay was developed and compared to thromboxane B2 (TX B2) enzyme-linked antibody assay and arachidonic acid-induced light transmission aggregometry (LTA).
- Measurements were performed in 22 healthy individuals and 63 patients treated with aspirin.
- Receiver operating characteristic (ROC) analysis was used to evaluate the MDA assay's ability to detect HTPR.
Main Results:
- MDA levels showed strong correlations with TX formation (R = 0.81) and LTA (R = 0.84) in patients.
- The MDA assay demonstrated high accuracy in detecting HTPR, with an area under the ROC curve of 0.965.
- An optimal cut-off of > 128 nmol/L for the MDA assay yielded 100% sensitivity and 91% specificity for detecting HTPR.
Conclusions:
- The new MDA assay is a reliable and specific method for detecting HTPR to aspirin.
- This assay presents a promising, potentially simpler alternative to current complex laboratory methods.
- Further evaluation of this potential bedside assay in clinical practice is warranted.
Abstract:
Aspirin is essential in secondary prevention of patients after myocardial infarction and with coronary artery disease. However, impaired pharmacodynamic response to aspirin is frequent (high on-treatment platelet reactivity [HTPR]). This leads to an enhanced prevalence of cardiovascular events and to an impaired clinical outcome. The current specific assays to evaluate aspirin antiplatelet effects are complex, time-consuming and demand for a high laboratory expertise. Therefore, we developed a potentially bedside assay based on the determination of malondialdehyde (MDA). MDA is a by-product of the thromboxane (TX) formation, which is synthesized in equimolar concentrations. In this study, we compared this MDA assay to the conventional assays in determination of pharmacodynamic aspirin response. For this, aspirin antiplatelet effects were measured in 22 healthy individuals and 63 aspirin treated patients using TX B2 formation enzyme-linked antibody assay, arachidonic acid induced light transmission aggregometry (LTA) and the new fluorometric MDA assay. In patients, MDA levels correlated well with TX formation (R = 0.81; 95% CI 0.69-0.88; p < 0.001) and LTA (R = 0.84; CI 0.74-0.91; p < 0.001). Receiver operating characteristic analyses revealed that the MDA assay does detect HTPR to aspirin sufficiently (area under the curve: 0.965; p < 0.001). The optimal cut-off was > 128 nmol/L (sensitivity of 100%, specificity of 91%). The new MDA assay is reliable in detecting HTPR. It is highly specific in the evaluation of antiplatelet effects by aspirin. This promising and potential bedside assay needs to be evaluated in clinical practice.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Biological Effects of Radiation
Effects of feedback
Feedback significantly modifies the gain of a control system. The gain of a system without feedback is altered by a factor of one plus GH, where G represents...
Self-Awareness and Its Effects

